Table 1.
Parameter | Probability | #/N | 95% CI | Range | Distribution | Source |
---|---|---|---|---|---|---|
All Years | ||||||
Technical success | 0.84 | 120/143 | 0.77–0.89 | 0.70–1.0 | Beta | Primary Data |
Post FAV fetal demise | 0.08 | 12/143 | 0.04–0.13 | 0.04–0.30 | Beta | Primary Data |
No FAV fetal demise | 0.06 | 4/72 | 0.02–0.12 | 0.00–0.20 | Beta | Beroukhim et al.23 |
TS: Biv outcome | 0.50 | 56/111 | 0.41–0.60 | 0.10–0.70 | Beta | Primary Data |
TU: Biv outcome | 0.16 | 3/19 | 0.04–0.35 | 0.00–0.50 | Beta | Primary Data |
2009–2017 | ||||||
Technical success | 0.94 | 67/71 | 0.88–0.98 | 0.70–1.00 | Beta | Primary Data |
Post FAV fetal demise | 0.04 | 3/71 | 0.01–0.10 | 0.01–0.20 | Beta | Primary Data |
TS: Biv outcome | 0.66 | 42/64 | 0.54–0.77 | 0.10–0.70 | Beta | Primary Data |
3-year Outcomes | ||||||
Survival | ||||||
Post TS FAV: Biv | 0.96 | 0.90–1.0 | Beta | Primary Data | ||
SV (MS/AS) | 0.77 | 0.64–0.86 | Beta | SVR18 | ||
Postnatal LE (months) | ||||||
Post TS FAV: BiV | 35.4 | 34.2–36.5 | Normal | Primary Data | ||
SV (MS/AS) | 31.0 | 28.3–33.7 | Normal | SVR18 | ||
6-year Outcomes | ||||||
Survival | ||||||
Post TS FAV: Biv | 0.92 | 0.83–1.0 | Beta | Primary Data | ||
SV (MS/AS) | 0.72 | 0.58–0.82 | Beta | SVR19 | ||
Postnatal LE (months) | ||||||
Post TS FAV: Biv | 69.4 | 66.2–72.5 | Normal | Primary Data | ||
SV (MS/AS) | 57.0 | 52.6–64.7 | Normal | SVR19 |
Biv = biventricular circulation; FAV = fetal aortic valvuloplasty; MS/AS = mitral stenosis/aortic stenosis; SVR = Single Ventricle Reconstruction trial secondary analysis; TS = technically successful; TU = technically unsuccessful